EGFR antibody (Extracellular Domain) (PE)
-
- Target See all EGFR Antibodies
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Binding Specificity
- Extracellular Domain
-
Reactivity
- Human
-
Host
- Rat
-
Clonality
- Monoclonal
-
Conjugate
- This EGFR antibody is conjugated to PE
-
Application
- Flow Cytometry (FACS)
- Specificity
- This antibody recognises the epidermal growth factor receptor (EGFR). This antibody binds to epitope B from EGFR (1, 2).Aff. Const.:6.7 x 10e-9 M
- Purification
- Affinity chromatography on Protein G
- Immunogen
- Extracellular domain of human EGF-receptor from head and neck carcinoma.
- Clone
- ICR10
- Isotype
- IgG2a
- Top Product
- Discover our top product EGFR Primary Antibody
-
-
- Application Notes
-
Flow Cytometry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Reconstitution
- Restore with 1.0 mL distilled water
- Buffer
- PBS containing 1 % BSA and 5 % Bovine Serum Albumin
- Preservative
- Sodium azide
- Precaution of Use
- Use of sodium azide as a preservative will substantially inhibit the enzyme activity of horseradish peroxidase.
- Handling Advice
- Avoid repeated freezing and thawing.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- EGFR (Epidermal Growth Factor Receptor (EGFR))
- Alternative Name
- EGFR / ERBB1 (EGFR Products)
- Background
- EGFR is over expressed in a high proportion of breast cancer cells and in a range of other carcinomas. High level expression of EGFR is often associated with advanced disease and poor prognosis.Synonyms: EGF Receptor, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, c-ErbB-1, erbB-1
- Gene ID
- 1956
- NCBI Accession
- NP_005219
- UniProt
- P00533
- Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
-